Mealey's (March 12, 2021, 12:48 PM EST) -- BROOKLYN, N.Y. — A federal judge in New York on March 10 partially granted a motion to dismiss in a securities class action lawsuit against a biopharmaceutical company and certain of its current and former senior executives, ruling that a pension plan has sufficiently pleaded its federal securities law claims against the company’s CEO and the company but has failed to properly plead scienter with regard to the remaining defendants....